Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Public ClinicalTrials.gov record NCT01598090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered With Telaprevir in Subjects With Genotype-1 Chronic Hepatitis C Who Are Treatment-naive or Relapsed on Prior Treatment With Peginterferon Alfa-2a and Ribavirin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Peginterferon Lambda-1a (Lambda) combined with Ribavirin (RBV) and Telaprevir (TVR) is effective in the treatment of chronic Hepatitis C (CHC) compared to Peginterferon Alfa-2a (alfa-2a) combined with RBV and Telaprevir.
Study identification
- NCT ID
- NCT01598090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 881 participants
Conditions and interventions
Conditions
Interventions
- Peginterferon Lambda-1a Biological
- Peginterferon Alfa-2a Biological
- Ribavirin Drug
- Telaprevir Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2012 (Actual)
- Primary completion
- Feb 4, 2015 (Actual)
- Completion
- May 15, 2015 (Actual)
- Last update posted
- Jul 31, 2019
2012 – 2015
United States locations
- U.S. sites
- 28
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Gastroenterology Associates, P.C. | Birmingham | Alabama | 35209 | — |
| The Kirklin Clinic | Birmingham | Alabama | 35294 | — |
| The University Of Alabama Of Birmingham | Birmingham | Alabama | 35294 | — |
| Anaheim Clinical Trials Llc | Anaheim | California | 92801 | — |
| Sc Clinical Research, Inc. | Garden Grove | California | 92844 | — |
| Va Long Beach Healthcare System | Long Beach | California | 90822 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Va Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
| University Of California, San Francisco/Sf General Hospital | San Francisco | California | 94110 | — |
| South Bay Ge Medical Group | Torrance | California | 90505 | — |
| Orlando Va Medical Center | Orlando | Florida | 32803 | — |
| Orlando Clinical Research Center | Orlando | Florida | 32809 | — |
| Infectious Disease Research Institute, Inc. | Tampa | Florida | 33614 | — |
| Gastrointestinal Specialists Of Georgia Pc | Marietta | Georgia | 30060 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| Saint Luke'S Transplant Specialists | Kansas City | Missouri | 64111 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28204 | — |
| Options Health Research, Llc | Tulsa | Oklahoma | 74104 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| Brooke Army Medical Center | Fort Sam Houston | Texas | 78234 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Clinical Research Centers Of America | Murray | Utah | 84123 | — |
| Metropolitan Research | Annandale | Virginia | 22003 | — |
| Bon Secours St. Mary'S Hospital Of Richmond, Inc. | Newport News | Virginia | 23602 | — |
| Digestive And Liver Disease Specialists | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01598090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01598090 live on ClinicalTrials.gov.